Contact
searchSearch
HMP Global

Embolization

Features

Arterial and Venous Embolization
Medtronic Announces Successful Early Commercial Use of Concerto Versa™ Detachable Coil
05/18/2026
First cases successfully performed by Rahul Patel, MD, at The Mount Sinai Hospital, NY, and Gloria Salazar, MD, UNC Hospitals, Chapel Hill Medtronic, a global leader in healthcare technology, today announced the first cases successfully...
First cases successfully performed by Rahul Patel, MD, at The Mount Sinai Hospital, NY, and Gloria Salazar, MD, UNC Hospitals, Chapel Hill Medtronic, a global leader in healthcare technology, today announced the first cases successfully...
First cases successfully...
05/18/2026
Vascular Disease Management
MSK Embolization
CUC America Announces Strategic Collaborations with Dr. Yuji Okuno and Dr. Osman Ahmed to Advance MSK Embolization and Expand Access to Minimally Invasive Pain Treatment in the United States
04/10/2026
Global pioneer of embolotherapy and leading U.S. interventional radiologist join forces with CUC America to build a scalable Office-Based Laboratory (OBL) platform New Baltimore, MI — April 9, 2026 — CUC America, a leading provider of...
Global pioneer of embolotherapy and leading U.S. interventional radiologist join forces with CUC America to build a scalable Office-Based Laboratory (OBL) platform New Baltimore, MI — April 9, 2026 — CUC America, a leading provider of...
Global pioneer of embolotherapy...
04/10/2026
Vascular Disease Management
Dr Mary Costantino speaks at ISET 2026.
ISET 2026
Uterine Fibroid Embolization in the OBL: Patient Selection and Workflow Optimization
04/02/2026
Mary Costantino, MD, FSIR
Dr Costantino outlines practical strategies for identifying appropriate candidates and streamlining procedural workflows in the OBL setting, with a focus on improving efficiency, patient outcomes, and overall practice success.
Dr Costantino outlines practical strategies for identifying appropriate candidates and streamlining procedural workflows in the OBL setting, with a focus on improving efficiency, patient outcomes, and overall practice success.
Dr Costantino outlines practical...
04/02/2026
Vascular Disease Management
Review
Cost-Effectiveness of Genicular Artery Embolization From an Interventional Cardiologist vs Interventional Radiologist Standpoint: A Model-Based Comparative Analysis
04/02/2026
Darshan Hullon, DO; Abiya Ahad, MBBS
This study conducted a model-based cost-effectiveness analysis comparing GAE performed by IRs and ICs for the treatment of symptomatic knee osteoarthritis.
This study conducted a model-based cost-effectiveness analysis comparing GAE performed by IRs and ICs for the treatment of symptomatic knee osteoarthritis.
This study conducted a...
04/02/2026
Vascular Disease Management
Original Research
Temporary Occlusion Embolectomy: A Cost-Effective Approach to Distal Embolic Protection in Peripheral Artery Disease
03/18/2026
Tom Davis, MD; Peter Dovgan, MD; Eric J. Dippel, MD
This retrospective observational case series evaluated embolic debris retrieval and procedural feasibility of temporary occlusion embolectomy during complex peripheral vascular interventions.
This retrospective observational case series evaluated embolic debris retrieval and procedural feasibility of temporary occlusion embolectomy during complex peripheral vascular interventions.
This retrospective observational...
03/18/2026
Vascular Disease Management
John Fritz Angle, MD
ISET 2026
AVM Embolization Strategies: Tools and Tactics That Work
02/10/2026
John Fritz Angle, MD
Interventional radiologist John Fritz Angle, MD, walked attendees through the evolving landscape of arteriovenous malformation (AVM) embolization.
Interventional radiologist John Fritz Angle, MD, walked attendees through the evolving landscape of arteriovenous malformation (AVM) embolization.
Interventional radiologist John...
02/10/2026
Vascular Disease Management
Embolization
Merit Medical Embosphere Microspheres Achieve CE Mark for Genicular Artery Embolization to Treat Knee Osteoarthritis in Europe
09/15/2025
Merit Medical Systems, Inc. announced that Embosphere® Microspheres are now indicated in the European Union for use in genicular artery embolization to treat patients with knee osteoarthritis.
Merit Medical Systems, Inc. announced that Embosphere® Microspheres are now indicated in the European Union for use in genicular artery embolization to treat patients with knee osteoarthritis.
Merit Medical Systems, Inc....
09/15/2025
Vascular Disease Management
Liquid Embolics
Instylla Gains U.S. FDA Premarket Approval for Embrace™ Hydrogel Embolic System
08/07/2025
BEDFORD, Mass., Aug. 7, 2025 /PRNewswire/ -- Instylla, Inc., a privately held company developing novel resorbable embolics for peripheral vascular embolization, announced premarket approval (PMA) from the U.S. Food and Drug Administration...
BEDFORD, Mass., Aug. 7, 2025 /PRNewswire/ -- Instylla, Inc., a privately held company developing novel resorbable embolics for peripheral vascular embolization, announced premarket approval (PMA) from the U.S. Food and Drug Administration...
BEDFORD, Mass., Aug. 7, 2025...
08/07/2025
Vascular Disease Management
Embolization
Embolx Launches Sniper G3: Revolutionizing Embolization With Enhanced Efficiency, Ease of Use, and Extended Shelf Life
07/28/2025
SUNNYVALE, Calif., July 28, 2025 /PRNewswire/ -- Embolx, a leader in advanced microcatheters for targeted embolization procedures, today announced the release of its next-generation Sniper G3 Balloon Occlusion Microcatheter. This third...
SUNNYVALE, Calif., July 28, 2025 /PRNewswire/ -- Embolx, a leader in advanced microcatheters for targeted embolization procedures, today announced the release of its next-generation Sniper G3 Balloon Occlusion Microcatheter. This third...
SUNNYVALE, Calif., July 28, 2025...
07/28/2025
Vascular Disease Management
Polymer-based coils
Embolization, Inc., Receives 510(k) Clearance for Non-Metal Coil Device
06/25/2025
06/25/2025
Vascular Disease Management
Interview
Minimally Invasive Treatment Options for Osteoarthritis-Related Knee Pain: Where Are We Now?
06/10/2025
Yan Epelboym, MD, MPH
Yan Epelboym, MD, MPH, discusses embolization and ablation for OA-related knee pain and why they are good options to consider for patients who have not responded to other nonsurgical treatments.
Yan Epelboym, MD, MPH, discusses embolization and ablation for OA-related knee pain and why they are good options to consider for patients who have not responded to other nonsurgical treatments.
Yan Epelboym, MD, MPH, discusses...
06/10/2025
Vascular Disease Management

Videos

Dr Mary Costantino speaks at ISET 2026.
ISET 2026
Uterine Fibroid Embolization in the OBL: Patient Selection and Workflow Optimization
04/02/2026
Mary Costantino, MD, FSIR
Dr Costantino outlines practical strategies for identifying appropriate candidates and streamlining procedural workflows in the OBL setting, with a focus on improving efficiency, patient outcomes, and overall practice success.
Dr Costantino outlines practical strategies for identifying appropriate candidates and streamlining procedural workflows in the OBL setting, with a focus on improving efficiency, patient outcomes, and overall practice success.
Dr Costantino outlines practical...
04/02/2026
Vascular Disease Management
Dr Parikh
ISET 2025
The Current Role of PAE in the Management of Prostate Cancer
03/18/2025
Nainesh Parikh
In this video from ISET2025, interventional radiologist Dr Nainesh Parikh discusses his presentation on the benefits of prostatic artery embolization in the treatment of prostate cancer.
In this video from ISET2025, interventional radiologist Dr Nainesh Parikh discusses his presentation on the benefits of prostatic artery embolization in the treatment of prostate cancer.
In this video from ISET2025,...
03/18/2025
Vascular Disease Management
Dr Wiechmann
OBL Corner
Why Embolotherapy Is Ideal for the Office-based Lab
03/10/2025
Bret N. Wiechmann, MD, FSIR, FAHA
Dr Bret Wiechmann reviews a presentation that he gave at GEST 2024, which explains how the OBL environment is a good fit for embolotherapy.
Dr Bret Wiechmann reviews a presentation that he gave at GEST 2024, which explains how the OBL environment is a good fit for embolotherapy.
Dr Bret Wiechmann reviews a...
03/10/2025
Vascular Disease Management
Dr. Maureen Kohi
ISET 2024
What's New in Uterine Artery Embolization for Fibroids and Adenomyosis; Patient Selection and Technique for Hemorrhoid Embolization
02/15/2024
Maureen Kohi, MD, FSIR, FAHA
In this video, Dr. Maureen Kohi discusses her ISET presentations on embolization for fibroids and andenomyosis and embolization techniques for hemorrhoid disease.
In this video, Dr. Maureen Kohi discusses her ISET presentations on embolization for fibroids and andenomyosis and embolization techniques for hemorrhoid disease.
In this video, Dr. Maureen Kohi...
02/15/2024
Vascular Disease Management
Gloria Salazar, MD, FSIR
ISET 2023
Treating Uterine AVMs, Hemorrhoids, Venous Ulcers, and Dealing With Complications
02/14/2023
Gloria Salazar, MD, FSIR
Gloria Salazar, MD, FSIR, discusses some of her presentations from ISET 2023, including treating uterine arteriovenous malformations, hemorrhoids, venous ulcers, and dealing with complications.
Gloria Salazar, MD, FSIR, discusses some of her presentations from ISET 2023, including treating uterine arteriovenous malformations, hemorrhoids, venous ulcers, and dealing with complications.
Gloria Salazar, MD, FSIR,...
02/14/2023
Vascular Disease Management
SIR 2022
Dr. Gloria Salazar at SIR 2022
06/15/2022
Gloria Salazar, MD, FSIR, spoke with VDM to discuss some of the topics she was presenting at SIR 2022 in Boston.
Gloria Salazar, MD, FSIR, spoke with VDM to discuss some of the topics she was presenting at SIR 2022 in Boston.
Gloria Salazar, MD, FSIR, spoke...
06/15/2022
Vascular Disease Management
Gloria Salazar, MD, FSIR
ISET 2022
Pelvic Venous Disease: New Nomenclature and Implications on Therapy
02/23/2022
Gloria Salazar, MD, FSIR
In this video from ISET 2022, Dr. Salazar discusses new nomenclature and implications on therapy for pelvic venous disease.
In this video from ISET 2022, Dr. Salazar discusses new nomenclature and implications on therapy for pelvic venous disease.
In this video from ISET 2022,...
02/23/2022
Vascular Disease Management
Videos
Uterine Fibroid Embolization: A Bellweather for the Rapidly Expanding Field of “Embolic Therapy”
04/21/2021
04/21/2021
Vascular Disease Management
Ghassan Abou-Alfa headshot
ASCO 2026
Immunotherapy Plus TACE Emerges as a New Option for Intermediate-Stage Hepatocellular Carcinoma
07/13/2026
Ghassan Abou-Alfa, MD, MBA
Ghassan Abou-Alfa, MD, discusses phase 3 EMERALD-3 results showing that adding STRIDE (tremelimumab plus durvalumab) to transarterial chemoembolization significantly improved progression-free survival in patients with unresectable...
Ghassan Abou-Alfa, MD, discusses phase 3 EMERALD-3 results showing that adding STRIDE (tremelimumab plus durvalumab) to transarterial chemoembolization significantly improved progression-free survival in patients with unresectable...
Ghassan Abou-Alfa, MD, discusses...
07/13/2026
Vascular Disease Management
Michael Pishvaian headshot
Interview
Intra-Arterial Gemcitabine for Patients With Locally Advanced Pancreatic Cancer
06/15/2026
Michael Pishvaian, MD, PhD
Michael Pishvaian, MD, PhD, discusses the phase 3 TIGeR-PaC study evaluating intra-arterial gemcitabine among patients with locally advanced pancreatic cancer.
Michael Pishvaian, MD, PhD, discusses the phase 3 TIGeR-PaC study evaluating intra-arterial gemcitabine among patients with locally advanced pancreatic cancer.
Michael Pishvaian, MD, PhD,...
06/15/2026
Vascular Disease Management
Dr Kak Khee Yeung speaks at ISET 2026.
ISET 2026
Can AI Be of Value in Predicting Type B Dissection Progression Over Time?
04/16/2026
Kak Khee Yeung, MD, PhD
Kak Khee Yeung, MD, PhD, explores the potential role of AI in predicting the progression of Type B aortic dissection over time.
Kak Khee Yeung, MD, PhD, explores the potential role of AI in predicting the progression of Type B aortic dissection over time.
Kak Khee Yeung, MD, PhD,...
04/16/2026
Vascular Disease Management
Dr Mouawad speaks at ISET 2026
ISET 2026
Advancing Thrombectomy and Autologous Blood Reinfusion for Pulmonary Embolism Treatment: Results from the AVENTUS Pivotal Study
04/09/2026
Nicolas J. Mouawad, MD, MPH, MBA
Dr Mouawad discusses the results of the AVENTUS pivotal trial.
Dr Mouawad discusses the results of the AVENTUS pivotal trial.
Dr Mouawad discusses the results...
04/09/2026
Vascular Disease Management
Dr S Jay Mathews speaks at ISET 2026
ISET 2026
Retrievable Scaffold Therapy: Results From Trials
04/07/2026
S. Jay Mathews, MD, MS, FACC, FSCAI
Dr Mathews reviews the latest clinical data, discusses evolving techniques, and highlights how retrievable scaffold technology is shaping the future of vascular intervention.
Dr Mathews reviews the latest clinical data, discusses evolving techniques, and highlights how retrievable scaffold technology is shaping the future of vascular intervention.
Dr Mathews reviews the latest...
04/07/2026
Vascular Disease Management
Dr Mary Costantino speaks at ISET 2026.
ISET 2026
Uterine Fibroid Embolization in the OBL: Patient Selection and Workflow Optimization
04/02/2026
Mary Costantino, MD, FSIR
Dr Costantino outlines practical strategies for identifying appropriate candidates and streamlining procedural workflows in the OBL setting, with a focus on improving efficiency, patient outcomes, and overall practice success.
Dr Costantino outlines practical strategies for identifying appropriate candidates and streamlining procedural workflows in the OBL setting, with a focus on improving efficiency, patient outcomes, and overall practice success.
Dr Costantino outlines practical...
04/02/2026
Vascular Disease Management
Dr Salazar speaks at ISET 2026
ISET 2026
Venous Valve Technology: When Will It Be Standard of Care?
04/01/2026
Gloria Salazar, MD, FSIR
Dr Salazar examines the current state of venous valve technologies, including recent clinical progress and the challenges that remain before widespread adoption.
Dr Salazar examines the current state of venous valve technologies, including recent clinical progress and the challenges that remain before widespread adoption.
Dr Salazar examines the current...
04/01/2026
Vascular Disease Management
Dr Gunnar Tepe speaks at ISET 2026
ISET 2026
The State of DCB Technology in 2026: Where Are We Going?
03/31/2026
Gunnar Tepe, MD
Dr. Tepe explores the latest clinical data, emerging innovations, and ongoing challenges shaping the field, offering insight into how DCB technology is redefining endovascular treatment strategies today—and where it may lead.
Dr. Tepe explores the latest clinical data, emerging innovations, and ongoing challenges shaping the field, offering insight into how DCB technology is redefining endovascular treatment strategies today—and where it may lead.
Dr. Tepe explores the latest...
03/31/2026
Vascular Disease Management
Dr Jacques Busquet speaks at ISET 2026.
ISET 2026
The Mystery of Post-EVAR Endotension
03/26/2026
Jacques Busquet, MD
In this video, renowned cardiovascular and endovascular surgeon Jacques Busquet, MD, from Clinique Val d'Or in Paris, France, explores the mystery of post-EVAR endotension, expanding on insights from his presentation at ISET 2026.
In this video, renowned cardiovascular and endovascular surgeon Jacques Busquet, MD, from Clinique Val d'Or in Paris, France, explores the mystery of post-EVAR endotension, expanding on insights from his presentation at ISET 2026.
In this video, renowned...
03/26/2026
Vascular Disease Management
Dr Sanjay Misra speaks at ISET 2026
ISET 2026
Renal Denervation for Refractory Hypertension: Indications, Data, and Outcomes
03/25/2026
Sanjay Misra, MD, FSIR, FAHA, FACR
Interventional radiologist Sanjay Misra, MD, FSIR, FAHA, FACR, from the Mayo Clinic, highlights key insights from his presentation on renal denervation for hypertension.
Interventional radiologist Sanjay Misra, MD, FSIR, FAHA, FACR, from the Mayo Clinic, highlights key insights from his presentation on renal denervation for hypertension.
Interventional radiologist...
03/25/2026
Vascular Disease Management

Presentations

John Fritz Angle, MD
ISET 2026
AVM Embolization Strategies: Tools and Tactics That Work
02/10/2026
John Fritz Angle, MD
Interventional radiologist John Fritz Angle, MD, walked attendees through the evolving landscape of arteriovenous malformation (AVM) embolization.
Interventional radiologist John Fritz Angle, MD, walked attendees through the evolving landscape of arteriovenous malformation (AVM) embolization.
Interventional radiologist John...
02/10/2026
Vascular Disease Management
Dr Sag
ISET 2025
Thyroid Artery Embolization vs Ablation
02/03/2025
Alan A. Sag, MD
Alan Alper Sag, MD, presented a discussion at ISET 2025 that compared thyroid artery embolization and radiofrequency ablation as minimally invasive alternatives to traditional surgical and medical treatments for thyroid disorders.
Alan Alper Sag, MD, presented a discussion at ISET 2025 that compared thyroid artery embolization and radiofrequency ablation as minimally invasive alternatives to traditional surgical and medical treatments for thyroid disorders.
Alan Alper Sag, MD, presented a...
02/03/2025
Vascular Disease Management
Mike Watts, MD, FSIR
AMP 2026
When Economics Meets Innovation: Matching Deep Venous Arterialization to the Right Site of Service
08/07/2026
Mike Watts, MD, FSIR
Dr Mike Watts examines an important question surrounding DVA: not simply whether the procedure can prevent amputation in patients with no-option CLTI, but how the economics of care delivery influence where and how it can be successfully...
Dr Mike Watts examines an important question surrounding DVA: not simply whether the procedure can prevent amputation in patients with no-option CLTI, but how the economics of care delivery influence where and how it can be successfully...
Dr Mike Watts examines an...
08/07/2026
Vascular Disease Management
Dr Yana Etkin
AMP 2026
Early Detection and Timely Reintervention Drive Success After Deep Venous Arterialization
08/07/2026
Yana Etkin, MD, FSVS, FACS
Yana Etkin, MD,  presented an in-depth review of strategies for identifying and managing failing DVA, emphasizing that long-term success depends not only on creating the DVA circuit but also on maintaining its patency through vigilant...
Yana Etkin, MD,  presented an in-depth review of strategies for identifying and managing failing DVA, emphasizing that long-term success depends not only on creating the DVA circuit but also on maintaining its patency through vigilant...
Yana Etkin, MD,  presented an...
08/07/2026
Vascular Disease Management
Alik Farber, MD
AMP 2026
Four-Year BEST-CLI Data Reinforce a Team-Based Future for Limb Salvage
08/07/2026
Alik Farber, MD
Alik Farber, MD, MBA, presented the latest 4-year findings from the landmark BEST-CLI trial. He challenged attendees to move beyond the long-standing debate of surgery vs endovascular intervention and instead embrace an evidence-based,...
Alik Farber, MD, MBA, presented the latest 4-year findings from the landmark BEST-CLI trial. He challenged attendees to move beyond the long-standing debate of surgery vs endovascular intervention and instead embrace an evidence-based,...
Alik Farber, MD, MBA, presented...
08/07/2026
Vascular Disease Management
Dr Eric Secemsky
AMP 2026
Defining Optimal Medical Therapy for CLTI in 2026
08/07/2026
Eric A. Secemsky, MD, MSc, RPVI, FACC, FAHA, FSCAI
Dr Eric Secemsky presented a review of the evidence supporting contemporary medical management for patients with PAD and CLTI, emphasizing that pharmacologic therapy remains an essential pillar of reducing cardiovascular events.
Dr Eric Secemsky presented a review of the evidence supporting contemporary medical management for patients with PAD and CLTI, emphasizing that pharmacologic therapy remains an essential pillar of reducing cardiovascular events.
Dr Eric Secemsky presented a...
08/07/2026
Vascular Disease Management
Dr Ralf Langhoff
AMP 2026
Retrograde Access Moves to the Forefront: Rethinking CTO Crossing Strategies
08/06/2026
Ralf Langhoff, MD
During a Thursday afternoon session at the Amputation Prevention Symposium 2026, Ralf Langhoff, MD, asked attendees to reconsider when retrograde access should be used for chronic total occlusion (CTO) interventions.
During a Thursday afternoon session at the Amputation Prevention Symposium 2026, Ralf Langhoff, MD, asked attendees to reconsider when retrograde access should be used for chronic total occlusion (CTO) interventions.
During a Thursday afternoon...
08/06/2026
Vascular Disease Management
Dr Ramon Varcoe
AMP 2026
Bioresorbable Below-the-Knee Technology Shows Durable Promise for CLTI
08/06/2026
Ramon L. Varcoe, MBBS, MS, PhD
Dr Ramon L. Varcoe presented an update on bioresorbable BTK technology, highlighting the growing body of evidence supporting the Esprit™ BTK drug-eluting resorbable scaffold (Abbott Cardiovascular) for the treatment of CLTI.
Dr Ramon L. Varcoe presented an update on bioresorbable BTK technology, highlighting the growing body of evidence supporting the Esprit™ BTK drug-eluting resorbable scaffold (Abbott Cardiovascular) for the treatment of CLTI.
Dr Ramon L. Varcoe presented an...
08/06/2026
Vascular Disease Management
Dr Pradeep Nair
AMP 2026
A New Approach to Crossing and Preparing Complex Peripheral Chronic Total Occlusions
08/06/2026
Pradeep K. Nair, MD, FACC, FSCAI
Dr Pradeep K. Nair presented the clinical rationale, engineering design, pivotal clinical data, and early real-world experience with the Santreva-ATK Endovascular Revascularization Catheter (AngioSafe).
Dr Pradeep K. Nair presented the clinical rationale, engineering design, pivotal clinical data, and early real-world experience with the Santreva-ATK Endovascular Revascularization Catheter (AngioSafe).
Dr Pradeep K. Nair presented the...
08/06/2026
Vascular Disease Management
S Jay Mathews, MD
AMP 2026
SELUTION SLR Highlights the Growing Role of Sirolimus Drug-Eluting Balloons in CLTI
08/06/2026
S. Jay Mathews, MD, MS, FACC, FSCAI
This presentation examined the evolving evidence supporting the SELUTION SLR sirolimus drug-eluting balloon (Cordis) as a treatment strategy for femoropopliteal and BTK PAD, with particular emphasis on complex CLTI.
This presentation examined the evolving evidence supporting the SELUTION SLR sirolimus drug-eluting balloon (Cordis) as a treatment strategy for femoropopliteal and BTK PAD, with particular emphasis on complex CLTI.
This presentation examined the...
08/06/2026
Vascular Disease Management
Tim Wittig, MD
AMP 2026
MOTIV BTK Trial Demonstrates Promising Early Outcomes for Sirolimus-Eluting Bioresorbable Scaffold in CLTI
08/05/2026
Tim Wittig, MD
Tim Wittig, MD, presents the primary outcomes from the MOTIV BTK Trial, which evaluated the safety and efficacy of the sirolimus-eluting bioresorbable scaffold MOTIV BTK.
Tim Wittig, MD, presents the primary outcomes from the MOTIV BTK Trial, which evaluated the safety and efficacy of the sirolimus-eluting bioresorbable scaffold MOTIV BTK.
Tim Wittig, MD, presents the...
08/05/2026
Vascular Disease Management
Dr Eric Scott
AMP 2026
Using Imaging to Choose Between Endovascular Therapy and Surgical Bypass
08/05/2026
Eric C. Scott, MD
Dr Eric Scott presents presents a case-based discussion on how advanced vascular imaging should guide the decision between an endovascular-first or surgical bypass-first approach for patients with PAD and CLTI.
Dr Eric Scott presents presents a case-based discussion on how advanced vascular imaging should guide the decision between an endovascular-first or surgical bypass-first approach for patients with PAD and CLTI.
Dr Eric Scott presents presents...
08/05/2026
Vascular Disease Management

Stay in the Know

Vascular Disease Management Newsletter

News

Arterial and Venous Embolization
Medtronic Announces Successful Early Commercial Use of Concerto Versa™ Detachable Coil
05/18/2026
First cases successfully performed by Rahul Patel, MD, at The Mount Sinai Hospital, NY, and Gloria Salazar, MD, UNC Hospitals, Chapel Hill Medtronic, a global leader in healthcare technology, today announced the first cases successfully...
First cases successfully performed by Rahul Patel, MD, at The Mount Sinai Hospital, NY, and Gloria Salazar, MD, UNC Hospitals, Chapel Hill Medtronic, a global leader in healthcare technology, today announced the first cases successfully...
First cases successfully...
05/18/2026
Vascular Disease Management
MSK Embolization
CUC America Announces Strategic Collaborations with Dr. Yuji Okuno and Dr. Osman Ahmed to Advance MSK Embolization and Expand Access to Minimally Invasive Pain Treatment in the United States
04/10/2026
Global pioneer of embolotherapy and leading U.S. interventional radiologist join forces with CUC America to build a scalable Office-Based Laboratory (OBL) platform New Baltimore, MI — April 9, 2026 — CUC America, a leading provider of...
Global pioneer of embolotherapy and leading U.S. interventional radiologist join forces with CUC America to build a scalable Office-Based Laboratory (OBL) platform New Baltimore, MI — April 9, 2026 — CUC America, a leading provider of...
Global pioneer of embolotherapy...
04/10/2026
Vascular Disease Management
Embolization
Merit Medical Embosphere Microspheres Achieve CE Mark for Genicular Artery Embolization to Treat Knee Osteoarthritis in Europe
09/15/2025
Merit Medical Systems, Inc. announced that Embosphere® Microspheres are now indicated in the European Union for use in genicular artery embolization to treat patients with knee osteoarthritis.
Merit Medical Systems, Inc. announced that Embosphere® Microspheres are now indicated in the European Union for use in genicular artery embolization to treat patients with knee osteoarthritis.
Merit Medical Systems, Inc....
09/15/2025
Vascular Disease Management
Liquid Embolics
Instylla Gains U.S. FDA Premarket Approval for Embrace™ Hydrogel Embolic System
08/07/2025
BEDFORD, Mass., Aug. 7, 2025 /PRNewswire/ -- Instylla, Inc., a privately held company developing novel resorbable embolics for peripheral vascular embolization, announced premarket approval (PMA) from the U.S. Food and Drug Administration...
BEDFORD, Mass., Aug. 7, 2025 /PRNewswire/ -- Instylla, Inc., a privately held company developing novel resorbable embolics for peripheral vascular embolization, announced premarket approval (PMA) from the U.S. Food and Drug Administration...
BEDFORD, Mass., Aug. 7, 2025...
08/07/2025
Vascular Disease Management
Embolization
Embolx Launches Sniper G3: Revolutionizing Embolization With Enhanced Efficiency, Ease of Use, and Extended Shelf Life
07/28/2025
SUNNYVALE, Calif., July 28, 2025 /PRNewswire/ -- Embolx, a leader in advanced microcatheters for targeted embolization procedures, today announced the release of its next-generation Sniper G3 Balloon Occlusion Microcatheter. This third...
SUNNYVALE, Calif., July 28, 2025 /PRNewswire/ -- Embolx, a leader in advanced microcatheters for targeted embolization procedures, today announced the release of its next-generation Sniper G3 Balloon Occlusion Microcatheter. This third...
SUNNYVALE, Calif., July 28, 2025...
07/28/2025
Vascular Disease Management
Polymer-based coils
Embolization, Inc., Receives 510(k) Clearance for Non-Metal Coil Device
06/25/2025
06/25/2025
Vascular Disease Management
Embolotherapy
Instylla Completes Submission of Premarket Approval Application for Embrace™ Hydrogel Embolic System
03/11/2025
BEDFORD, Mass., March 11, 2025 /PRNewswire/ -- Instylla, Inc., a privately held clinical-stage company developing solutions for peripheral vascular embolotherapy, announced that it recently submitted to the U.S. Food and Drug Administration...
BEDFORD, Mass., March 11, 2025 /PRNewswire/ -- Instylla, Inc., a privately held clinical-stage company developing solutions for peripheral vascular embolotherapy, announced that it recently submitted to the U.S. Food and Drug Administration...
BEDFORD, Mass., March 11, 2025...
03/11/2025
Vascular Disease Management
Embolotherapy
Instylla Announces FDA Clearance of Tembo™ Embolic System
01/29/2025
Instylla, Inc., a privately held clinical-stage company developing solutions for peripheral vascular embolotherapy, has announced the FDA 510(k) clearance of the Tembo™ Embolic System.
Instylla, Inc., a privately held clinical-stage company developing solutions for peripheral vascular embolotherapy, has announced the FDA 510(k) clearance of the Tembo™ Embolic System.
Instylla, Inc., a privately held...
01/29/2025
Vascular Disease Management
News
Fluidx Medical Reveals New Embolic Platform for Internal Bleeding, Tumor Treatment, and Other Uses
11/30/2023
Salt Lake City (UT) – Fluidx Medical today released information about their new ULTRA™ embolic platform designed to make therapeutic embolization procedures safer, better, and faster.   Embolization is a minimally invasive...
Salt Lake City (UT) – Fluidx Medical today released information about their new ULTRA™ embolic platform designed to make therapeutic embolization procedures safer, better, and faster.   Embolization is a minimally invasive...
Salt Lake City (UT) – Fluidx...
11/30/2023
Vascular Disease Management
Press Release
Next-Generation Microcatheter for Embolic Agent Delivery Cleared by the FDA
11/30/2023
Park City, Utah USA, November 30, 2023 – Transit Scientific, a Utah-based medical device company specializing in innovative solutions for vascular procedures, has announced the FDA clearance of its microcatheter designed for the precise...
Park City, Utah USA, November 30, 2023 – Transit Scientific, a Utah-based medical device company specializing in innovative solutions for vascular procedures, has announced the FDA clearance of its microcatheter designed for the precise...
Park City, Utah USA, November...
11/30/2023
Vascular Disease Management
Radiation-Reducing Tech
Hoag First in California to Bring Radiation-Reducing Technology to Complex Vascular Care
08/18/2026
Patients undergoing complex aortic aneurysm repair at Hoag now have access to one of the most advanced image-guided technologies available.
Patients undergoing complex aortic aneurysm repair at Hoag now have access to one of the most advanced image-guided technologies available.
Patients undergoing complex...
08/18/2026
Vascular Disease Management
pVasc NET (Vesalio)
Thrombectomy
Vesalio Announces FDA 510(k) Clearance of pVasc NET, a Next-Generation Peripheral Mechanical Thrombectomy Device With Integrated Distal Filter
08/17/2026
New device expands Vesalio’s pVasc platform with integrated clot-capture technology designed to retain clot fragments during retrieval.
New device expands Vesalio’s pVasc platform with integrated clot-capture technology designed to retain clot fragments during retrieval.
New device expands Vesalio’s...
08/17/2026
Cath Lab Digest
JANE-2 project
Green Paper
Tumor Ablation Review Maps Next Phase of Cancer Care
08/14/2026
Laura Simson, MA
The EU Joint Action Networks of Expertise on Cancer (JANE-2) green paper examines emerging applications and strategies for integrating physical tumor ablation methods into oncology care.
The EU Joint Action Networks of Expertise on Cancer (JANE-2) green paper examines emerging applications and strategies for integrating physical tumor ablation methods into oncology care.
The EU Joint Action Networks of...
08/14/2026
Vascular Disease Management
Intravascular Lithotripsy
FastWave Medical Gains FDA IDE Approval to Begin Pivotal Trial of Artero Peripheral IVL System
08/12/2026
The U.S. pivotal study will evaluate FastWave's electric IVL system in patients with peripheral artery disease.
The U.S. pivotal study will evaluate FastWave's electric IVL system in patients with peripheral artery disease.
The U.S. pivotal study will...
08/12/2026
Cath Lab Digest
Embolic Technologies
Fluidx Medical Closes Financing to Advance Next-Generation Embolic Platform
08/12/2026
SALT LAKE CITY, Utah — August 6, 2026 — Fluidx Medical Technology, Inc., a developer of innovative embolic technologies, today announced the successful closing of financing to fund development and growth. The financing follows significant...
SALT LAKE CITY, Utah — August 6, 2026 — Fluidx Medical Technology, Inc., a developer of innovative embolic technologies, today announced the successful closing of financing to fund development and growth. The financing follows significant...
SALT LAKE CITY, Utah — August 6,...
08/12/2026
Vascular Disease Management
Phase 3 Randomized Clinical Trial
TACE Plus Ablation Improves Survival in Unresectable HCC Compared With TACE Alone
08/11/2026
Laura Simson, MA
Adding selective radiofrequency ablation after transarterial chemoembolization significantly improved survival outcomes among patients with liver-confined, unresectable hepatocellular carcinoma, according to the phase 3 TORCH randomized...
Adding selective radiofrequency ablation after transarterial chemoembolization significantly improved survival outcomes among patients with liver-confined, unresectable hepatocellular carcinoma, according to the phase 3 TORCH randomized...
Adding selective radiofrequency...
08/11/2026
Vascular Disease Management
CANSCAN Participant using VxWave
autonomous Ultrasound Imaging
Vexev Raises $6M to Accelerate U.S. Commercialization of Autonomous Vascular Imaging Platform
08/10/2026
The announcement follows successful results in a multi-site clinical study with U.S. Renal Care, one of the nation's largest dialysis providers, showing early clinical validation of VxWave in routine dialysis clinic workflows.
The announcement follows successful results in a multi-site clinical study with U.S. Renal Care, one of the nation's largest dialysis providers, showing early clinical validation of VxWave in routine dialysis clinic workflows.
The announcement follows...
08/10/2026
Cath Lab Digest
Press Release
Fluidx Completes Submission of Premarket Approval Application for the GPX® Embolic Device
07/24/2026
Salt Lake City (UT) – 07/24/2026 Fluidx Medical Technology, Inc., a clinical stage medical device company advancing its portfolio of embolic technologies, announced that it recently submitted to the U.S. Food and Drug Administration (FDA) the...
Salt Lake City (UT) – 07/24/2026 Fluidx Medical Technology, Inc., a clinical stage medical device company advancing its portfolio of embolic technologies, announced that it recently submitted to the U.S. Food and Drug Administration (FDA) the...
Salt Lake City (UT) – 07/24/2026...
07/24/2026
Vascular Disease Management
Thrombectomy
THUNDER Study Demonstrates Penumbra’s THUNDERBOLT is Safe and Effective for Stroke Care
07/22/2026
ALAMEDA, Calif. – Penumbra, Inc. announced the results of THUNDER, an Investigational Device Exemption (IDE) study, to evaluate the safety and effectiveness of THUNDERBOLT™, the company’s novel...
ALAMEDA, Calif. – Penumbra, Inc. announced the results of THUNDER, an Investigational Device Exemption (IDE) study, to evaluate the safety and effectiveness of THUNDERBOLT™, the company’s novel...
ALAMEDA, Calif....
07/22/2026
Cath Lab Digest
Stroke Interventions
Imperative Care Launches Ikon 24 Pro Guidewire, Enhancing the Zoom Stroke System to Support More Efficient Stroke Procedures
07/17/2026
CAMPBELL, Calif., July 16, 2026 — Imperative Care, a medical technology company focused on advancing treatments for patients suffering from thromboembolic disease, today announced the launch of the Ikon™ 24 Pro Guidewire, a next-generation...
CAMPBELL, Calif., July 16, 2026 — Imperative Care, a medical technology company focused on advancing treatments for patients suffering from thromboembolic disease, today announced the launch of the Ikon™ 24 Pro Guidewire, a next-generation...
CAMPBELL, Calif., July 16, 2026...
07/17/2026
Vascular Disease Management

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use